1. Home
  2. AMPG vs CING Comparison

AMPG vs CING Comparison

Compare AMPG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$6.55

Market Cap

51.7M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.92

Market Cap

59.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPG
CING
Founded
2002
2012
Country
United States
United States
Employees
47
14
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
59.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMPG
CING
Price
$6.55
$4.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$34.50
AVG Volume (30 Days)
6.5M
646.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$102.41
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$3.16
52 Week High
$10.11
$11.89

Technical Indicators

Market Signals
Indicator
AMPG
CING
Relative Strength Index (RSI) 50.30 51.99
Support Level $2.56 $3.34
Resistance Level $10.11 $5.30
Average True Range (ATR) 1.31 0.36
MACD -0.27 0.03
Stochastic Oscillator 31.37 57.67

Price Performance

Historical Comparison
AMPG
CING

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: